View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Kinaxis
14 May 2019

Kinaxis Positioned as a Leader in Gartner’s Magic Quadrant

Kinaxis has announced that the company has been positioned as a Leader in Gartner’s 2019 Magic Quadrant for Sales and Operations Planning (S&OP) Systems of Differentiation (SOD) for the third consecutive time.

In this report, Gartner analyses supply chain planning software solutions that enable a Stage 4 or higher sales and operations planning (S&OP) maturity process. A complimentary copy of the report can be downloaded from Kinaxis.

With customers and partners in every region around the globe, Kinaxis provides a unique concurrent end-to-end planning solution for a wide range of vertical markets. Kinaxis was also recently named a leader in the Gartner Magic Quadrant for supply chain planning systems of record.

CEO of Kinaxis John Sicard said: “Kinaxis has a strong history of market leadership and innovation around digital transformations.

“Our pioneering concurrent planning technique and digital supply chain twin capabilities give companies the power to instantly and continuously balance every aspect of their end-to-end supply chains, and immediately see and understand the potential financial and functional impact of changes.

“We continue to work in collaboration with our customers, partners and stakeholders on purposeful applications of artificial intelligence/machine learning, advanced analytics and prescriptive automation to enable confident, aligned decision-making in the multi-enterprise supply chain. As a result, we’re able to deliver more value for our customers and empower them to accelerate their maturity journey.”

Gartner defines Stage 4 S&OP maturity as the Collaborate stage. The report states, “In this stage, the S&OP system creates a demand-driven, profitable supply response across the increasingly extended supply chain, taking into account internal resources and trading partner capabilities. Potential benefits are outside-in oriented and include improvements in gross margin, working capital and market share.”

A single Cloud-based software as a service (SaaS) platform, code base and user interface, RapidResponse integrates functional planning activities and ties them directly into the S&OP process. Planners can collaborate across functions and organisations and explore the financial and operational impacts of decisions quickly and collaboratively, helping companies make better trade-offs across competing metrics both at the time of plan development or when mitigating risk due to unplanned events.

Kinaxis delivers S&OP capabilities that help customers:

  • Break down silos by planning concurrently across hierarchies, organisational boundaries and time horizons
  • Profitably change and shape forecast demand by aligning and balancing consensus demand and aggregate supply plans
  • Make confident decisions faster by evaluating multiple supply-demand balancing scenarios against key corporate metrics
  • Measure progress by setting and monitoring various financial targets and acceptable variability while maintaining S&OP assumptions

For further information, you can request a complimentary copy of the full Magic Quadrant for S&OP SOD report by making an enquiry using the contact form.

Supply chains in the life sciences sector are about as complex as they come. As biomedical advancements trigger a continuous stream of new product introductions,...
Using a single planning platform, Kinaxis unifies your supply chain planning to streamline your processes, break down silos and plan concurrently across every area of...
As a company with a 125-year history of improving the health and well-being of people worldwide, MSD (known as Merck & Co in the US...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology